RKResul Karakuş

Resul Karakuş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Resul Karakuş has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Emin Umit Bagriacik

    Department of Immunology, Faculty of Medicine, Gazi University, Ankara, Turkiye

    2 shared publications
  • Esin Senol

    Affiliation Department of Infectious Diseases and Clinical Microbiology, Gazi University, Faculty of Medicine, Ankara, Türkiye

    2 shared publications
  • Melek Yaman

    Affiliation Department of Immunology, Gazi University, Faculty of Medicine, Ankara, Türkiye

    2 shared publications
  • Alev Eroglu Altinova

    Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkiye

    1 shared publication
  • Alpay Azap

    Department of Infectious Diseases and Clinical Microbiology, Ankara University Faculty of Medicine, Ankara, Turkey

    1 shared publication
  • Ateş Karateke

    İstanbul Medeniyet University, Göztepe Training and Research Hospital, Clinic of Obstetrics and Gynecology, İstanbul, Turkey

    1 shared publication

Latest Publications

  • Effect of IL-34 on Macrophage Polarization

    by Meral Sarper, Resul Karakuş

    A cytokine recently found to play a role in monocyte survival has been termed interleukin 34 (IL-34). This cytokine plays a significant role in various physiological processes, including the regulation of cytokine and chemokine expression, differentiation of immune cells, and cell proliferation. In pathological conditions, IL-34 may mirror the pathophysiology of the disease involved, and simultaneously promote the growth and survival of myeloid cells, thereby maintaining homeostasis in the body. Increased levels of IL-34 have been shown in inflammation, autoimmune diseases, infections, and cancer. However, some studies reported that decreased levels IL-34 can be associated with several conditions such as neurological diseases.IL-34 macrophage phenotype is controlled with an immunosuppressive activity. Macrophages are heterogeneous both in function and phenotype. Depending on its biological characteristics and activity on macrophage polarization, IL-34 has been believed to have a therapeutic potential in the treatment of some diseases. The aim of this review is to discuss the role of IL-34 on macrophage polarization.

  • Open Access

    Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases

    by Umit Bagriacik, Resul Karakus, Melek Yaman, Nihan Oruklu, Milat Araz, Zafer Kalayci, Hasan Selcuk Ozger, Yesim Yildiz, Esin Senol

    Interleukin 40 (IL-40) is a novel cytokine that has been associated with B lymphocytes, particularly IgA-secreting cells in gut mucosa. Considering mucosal association of IL-40, we aimed to determine serum IL-40 levels in patients with Covid-19. We compared IL-40 concentrations in healthy people to both patients with mild symptoms of SARS-CoV-2 infection and pneumonia. IL-40 was measured by ELISA. Serum IgA levels were tested by nephelometry. For the first time, we demonstrated that SARS-CoV-2 infection increased serum IL-40 levels significantly. The elevation of IL-40 in serum was related to severity of the infection. Therefore, IL-40 concentrations were quite higher in patients with symptoms of pneumonia. Our findings indicated that IgA and NETosis biomarkers were related with IL-40 increase. Based on these findings, we speculated that IL-40 would be associated with immune activities in the mucosa of the lungs of SARS-CoV-2-infected patients. This association may be linked to a mechanism that has a control on IgA and NETosis.


  • Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients

    by Özlem Kanburoğlu Meletli, Alev Altınova, Başak Bolayır, Resul Karakuş, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, İlHan Yetkin, Füsun Saadet Toruner


  • Open Access

    Koroner arter baypass cerrahisinde statinin antikardiyolipin antikor seviyelerine etkisi

    by Levent Enver, Gürsel Levent Oktar, Resul Karakuş, Mustafa Arslan

    Objectives: The aim of this research is to study the link between lipid lowering mechanism and other beneficial biological effects of statin in patients of coronary bypass surgery by revealing the relation of preoperative statin on pre- , peri- and postoperative cardiolipin IgG and IgM antibody levels. The case in open cardiac surgery was not keeping the heart beating only but preventing or minimizing the myocardial injury. For this reason, a new method for preservation of blood elements and myocardium must be uncovered. Material and Methods: Thirty patients with coronary ischemic disease whose scheduled to undergo elective coronary artery bypass graft surgery and fitting the criteria for our research were divided in to two groups, those on standard lipid lowering therapy using atorvastatin ( 40 mg/day ) for at least 7 days prior to surgery (group A) and second group those without regular lipid lowering therapy preoperatively (B). All the parameters were documented and recorded, including demographic, hemodynamic, laboratory and surgical technique with outcome. Results: The recorded parameters and values were analyzed using the following tests in computer program: Kolmogorov- Smirnov test, student t test, paired t test and Chi- square test. All results were scheduled in 6 tables for simple and better evaluation. Conclusion: The findings support the beneficial effects of statin in the perioperative and early postoperative (first 24 hours) in open cardiac surgery.

  • Open Access

    INTERFERENCE IN IMMUNOASSAYS

    by Eugene Gıtongorı Mogaka, Resul Karakuş, E. Ümit Bağriaçik

    Immunoassays are simple, efficient and reliable means for testing patient samples in the modern hospital. Their specificity and sensitivity have provided robust means by which detection of analytes can be achieved with ease. The underlying principle of antigen-antibody reactions forming a measurable complex exposes immunoassays to possible interference from proteins and other reactants with structural similarities to antibodies and or the analytes. Accounting for the sensitivity of the test and its reliability, the impact of interferents both endogenous like autoantibodies and exogenous factors like drugs, involved in the assay is worth investigating since the alternative would be producing unreliable results. Insights for developing tests for assessing discordant results following troubleshooting of immunoassays as possible remedial measures have been provided.


  • Effects of skin‐to‐skin contact on afterpain and postpartum hemorrhage: A randomized controlled trial

    by Yasemin Aydin Kartal, Leyla Kaya, Saadet Yazici, Betül Engin, Resul Karakus

    This study determined the effects of skin‐to‐skin contact between the mother and the infant during the third stage of labor on postpartum hemorrhage and pain. This assessor‐blinded randomized controlled trial was conducted with primiparous women. Skin‐to‐skin contact interventions between the infants and their mothers occurred for 30 min after birth (n = 34), whereas the infants in the control group were provided routine care (n = 34). Data were gathered using a Personal Information Form, the Visual Analog Scale‐Pain, postpartum bleeding follow‐up bags, and records of blood oxytocin and beta endorphin levels. There was no significant difference in beta‐endorphin levels in both groups (p = 0.771), whereas it was determined that the 30th min oxytocin level was significantly higher in the intervention group (The Visual Analog Scale‐Pain score at the postpartum sixth hour was significantly lower in the intervention group. It was found that skin‐to‐skin contact made at the third stage of labor reduced the amount of postpartum hemorrhage. The results of this study suggested that skin‐to‐skin contact intervention may have beneficial effects on postpartum pain and postpartum hemorrhage in the early postpartum period


  • Open Access

    Serial measurement of cytokines strongly predict COVID-19 outcome

    by Hasan Selcuk Ozger, Resul Karakus, Elif Nazli Kuscu, Umit Emin Bagriacik, Nihan Oruklu, Melek Yaman, Melda Turkoglu, Gonca Erbas, Aysegul Yucel Atak, Esin Senol

    Purpose: Cytokines are major mediators of COVID-19 pathogenesis and several of them are already being regarded as predictive markers for the clinical course and outcome of COVID-19 cases. A major pitfall of many COVID-19 cytokine studies is the lack of a benchmark sampling timing. Since cytokines and their relative change during an infectious disease course is quite dynamic, we evaluated the predictive value of serially measured cytokines for COVID-19 cases. Methods: In this single-center, prospective study, a broad spectrum of cytokines were determined by multiplex ELISA assay in samples collected at admission and at the third day of hospitalization. Appropriateness of cytokine levels in predicting mortality were assessed by receiver-operating characteristic (ROC) analyses for both sampling times in paralel to conventional biomarkers. Results: At both sampling points, higher levels of IL-6, IL-7, IL-10, IL-15, IL-27 IP-10, MCP-1, and GCSF were found to be more predictive for mortality (p<0.05). Some of these cytokines, such as IL-6, IL-10, IL-7 and GCSF, had higher sensitivity and specificity in predicting mortality. AUC values of IL-6, IL-10, IL-7 and GCSF were 0.85 (0.65 to 0.92), 0.88 (0.73 to 0.96), 0.80 (0.63 to 0.91) and 0.86 (0.70 to 0.95), respectively at hospital admission. Compared to hospital admission, on the 3rd day of hospitalization serum levels of IL-6 and, IL-10 decreased significantly in the survivor group, unlike the non-survivor group (IL-6, p = 0.015, and IL-10, p = 0.016). Conclusion: Our study results suggest that single-sample-based cytokine analyzes can be misleading and that cytokine levels measured serially at different sampling times provide a more precise and accurate estimate for the outcome of COVID-19 patients.


  • Maternal death due to COVID-19: is there anything that changed during the treatment? A case report

    by Pınar Kumru, Ebru Çöğendez, Eralp Bulutlar, Fırat Ortak, Neslihan Başkılıç, Tülin Yollu, Resul Karakuş, Semra Kayataş

    Objective We present a case of maternal death due to COVID-19 and aimed to review our COVID-19 management strategies during pregnancy and changing strategies at different times of the epidemic through the present case. Case(s) Our patient was 35 years old, gravida 2, parity 1, 28 weeks pregnant, who admitted to the emergency service of our hospital for the first time with the complaints of severe dry cough, respiratory distress, fever, abdominal pain and vomiting, with suspected COVID-19. She was admitted to the delivery room. As the oxygen need increased within hours and the oxygen saturation decreased to 60%, the patient was intubated 21 hours after hospitalization and was admitted to our second level adult intensive care unit. Due to the development of fetal distress 1 hour after intubation, the patient was taken to emergency cesarean section. Four days after the operation, the patient died due to cardiopulmonary arrest in the 3rd level intensive care unit of the hospital where she was transferred. Conclusion This report demonstrates that COVID-19 can be severe in a pregnant woman, that the importance of early diagnosis and treatment, the difficulties of clinical management in case of progression of the disease, and ultimately, the maternal and neonatal consequences can be devastating.

  • Open Access

    Myometrial thickness overlying cesarean scar pregnancy is significantly associated with isthmocele formation in the third month of the postoperative period

    by Resul Karakuş, Sultan Seren Karakuş, Burak Güler, Gökhan Ünver, Enis Özkaya

    Objective: To determine some associated factors for isthmocele formation 3 months after the treatment of cesarean scar pregnancy (CSP). Materials and Methods: This is a prospective consecutive case series of CSP managed by fertility preservation modalities at a single tertiary care center from May 2016 to March 2019 (n=95). Patients with a diagnosis of CSP were identified and followed prospectively to collect data on the patients' demographics; detailed medical, surgical, and social history; symptoms; imaging and laboratory parameters at the time of CSP diagnosis and during treatment; treatment modalities, myometrial thickness; and outcomes in terms of isthmocele formation. Results: Mean myometrial thickness overlying scar pregnancy was significantly lower in the group with isthmocele formation, and the mean gestational age of scar pregnancy was also significantly lower in the group with isthmocele formation following treatment of scar pregnancy (p<0.05). Multivariate regression analysis was conducted to determine associations between certain variables and isthmocele development, which revealed that the gestational age of scar pregnancy and myometrial thickness were significantly associated with isthmocele formation. Conclusion: Myometrial thickness and gestational age of scar pregnancy were significantly associated with isthmocele formation 3 months after treatment.


  • Postpartum kanamanın önlenmesi ve tedavisinde kullanılan sentetik oksitosinin postpartum depresyon ile ilişkisi

    by Resul Karakuş, Çiğdem Pulatoğlu

    Objective:The aim of this study was to examine the relationship between postpartum synthetic oxytocin administration and the development of depressive and anxiety disorders after delivery.Materiyal and methods: We hypothesized that women exposed to postpartum exogenous oxytocin would have a reduced risk of postpartum depressive and anxiety disorders compared with those without exposure. The cases were examined under two groups as "Oxytocin users" (n = 100) and "Control" (n = 100) groups . Oxytocin group was given introvenous oxytocin just after the delivery for postpartum hemorrhage prevention and treatment. Questionnaires of depression and maternal anxiety were performed at the sixth week after the delivery. Results: The incidence of depression (4%) in the oxytocin group was significantly lower than the control group (14%) (p: 0.026, p <0.05). Patients who do not use oxytocin have a 3.9-fold greater risk of developing depression. We identified a relationship between using oxytocin for postpartum hemorragie and decreased postpartum depressive symptoms. Conclusion: Our findings suggest using exogenous oxytocin may contribute to postpartum symptoms of depression and anxiety among women. Future research should watch the longitudinal role of exogenous oxytocin in maternal mood and anxiety, the safety of high-dose long-term use of oxytocin.